Øyvind Melien

906 total citations
25 papers, 401 citations indexed

About

Øyvind Melien is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Øyvind Melien has authored 25 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Economics and Econometrics. Recurrent topics in Øyvind Melien's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Birth, Development, and Health (3 papers). Øyvind Melien is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Birth, Development, and Health (3 papers). Øyvind Melien collaborates with scholars based in Norway, Germany and France. Øyvind Melien's co-authors include Thoralf Christoffersen, Dagny Sandnes, Magne Refsnes, Oddgeir L. Holmen, Anne Cathrine Staff, Hannele Laivuori, Anne Stine Kvehaugen, Ralf Dechend, Randi Winsnes and G. Hege Thoresen and has published in prestigious journals such as FEBS Letters, Hypertension and European Journal of Biochemistry.

In The Last Decade

Øyvind Melien

25 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Øyvind Melien Norway 11 125 82 71 58 47 25 401
Sudarshan Hebbar United States 11 104 0.8× 16 0.2× 42 0.6× 57 1.0× 105 2.2× 17 490
Katalin Tóth Hungary 15 101 0.8× 14 0.2× 143 2.0× 19 0.3× 38 0.8× 44 540
Stefania Giuliano Italy 11 176 1.4× 9 0.1× 28 0.4× 44 0.8× 110 2.3× 23 584
D. M. Burley Switzerland 8 119 1.0× 16 0.2× 56 0.8× 18 0.3× 59 1.3× 16 634
Inga Peter United States 12 58 0.5× 6 0.1× 73 1.0× 24 0.4× 65 1.4× 17 374
Jin Peng China 14 205 1.6× 8 0.1× 21 0.3× 11 0.2× 41 0.9× 42 588
Jung‐Nien Lai Taiwan 11 70 0.6× 5 0.1× 24 0.3× 41 0.7× 30 0.6× 31 415
Karine Sargsyan Austria 9 94 0.8× 11 0.1× 25 0.4× 13 0.2× 32 0.7× 32 312
Monica Fujii United States 10 103 0.8× 46 0.6× 42 0.6× 4 0.1× 59 1.3× 28 561
Yasuhiro Endo Japan 14 92 0.7× 9 0.1× 20 0.3× 8 0.1× 93 2.0× 38 414

Countries citing papers authored by Øyvind Melien

Since Specialization
Citations

This map shows the geographic impact of Øyvind Melien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Øyvind Melien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Øyvind Melien more than expected).

Fields of papers citing papers by Øyvind Melien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Øyvind Melien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Øyvind Melien. The network helps show where Øyvind Melien may publish in the future.

Co-authorship network of co-authors of Øyvind Melien

This figure shows the co-authorship network connecting the top 25 collaborators of Øyvind Melien. A scholar is included among the top collaborators of Øyvind Melien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Øyvind Melien. Øyvind Melien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wettermark, Björn, Amanj Kurdi, Caridad Pontes, et al.. (2022). Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries. Frontiers in Pharmacology. 13. 873556–873556. 9 indexed citations
2.
Tummers, Marcia, Kari Jorunn Kværner, Laura Sampietro-Colom, et al.. (2020). On the integration of early health technology assessment in the innovation process: reflections from five stakeholders. International Journal of Technology Assessment in Health Care. 36(5). 481–485. 15 indexed citations
3.
Hulstaert, Frank, et al.. (2020). Closing the cycle of innovation in healthcare in Europe. International Journal of Technology Assessment in Health Care. 36(2). 75–79. 3 indexed citations
4.
Godman, Brian, Alec Morton, Christoph Baumgärtel, et al.. (2017). Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context. Medical Research Archives. 5(3). 13 indexed citations
5.
Leyens, Lada, Étienne Richer, Øyvind Melien, Wolfgang Ballensiefen, & Angela Brand. (2015). Available Tools to Facilitate Early Patient Access to Medicines in the EU and the USA: Analysis of Conditional Approvals and the Implications for Personalized Medicine. Public Health Genomics. 18(5). 249–259. 10 indexed citations
6.
Kvehaugen, Anne Stine, Øyvind Melien, Oddgeir L. Holmen, et al.. (2014). Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study. BMC Medical Genetics. 15(1). 28–28. 22 indexed citations
7.
Elsais, Ahmed, et al.. (2013). Medikamenter som kan utløse og forverre myasthenia gravis. Tidsskrift for Den norske legeforening. 133(3). 296–299. 8 indexed citations
8.
Björkhem‐Bergman, Linda, Eva Karlsson, Richard Laing, et al.. (2013). Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. European Journal of Clinical Pharmacology. 69(S1). 73–78. 69 indexed citations
9.
Kvehaugen, Anne Stine, Øyvind Melien, Oddgeir L. Holmen, et al.. (2013). Single Nucleotide Polymorphisms in G Protein Signaling Pathway Genes in Preeclampsia. Hypertension. 61(3). 655–661. 42 indexed citations
10.
Holmen, Oddgeir L., Solfrid Romundstad, & Øyvind Melien. (2010). Association Between the G Protein  3 Subunit C825T Polymorphism and the Occurrence of Cardiovascular Disease in Hypertensives: The Nord-Trondelag Health Study (HUNT). American Journal of Hypertension. 23(10). 1121–1127. 11 indexed citations
11.
Opdal, Siri H., et al.. (2010). The brain‐derived neutrophic factor val66met polymorphism and sudden unexpected infant death. Acta Paediatrica. 100(1). 86–89. 2 indexed citations
12.
Romundstad, Solfrid, Øyvind Melien, & Jostein Holmen. (2010). The G Protein  3 Subunit C825T Polymorphism Is Associated With Microalbuminuria in Hypertensive Women and Cardiovascular Disease in Hypertensive Men. American Journal of Hypertension. 23(10). 1114–1120. 3 indexed citations
13.
Melien, Øyvind, et al.. (2008). G protein β3 subunit C825T polymorphism modifies the presentation of temporal lobe epilepsy. Acta Neurologica Scandinavica. 117(s188). 62–66. 1 indexed citations
14.
Sioud, Mouldy & Øyvind Melien. (2006). Treatment Options and Individualized Medicine. Humana Press eBooks. 361. 327–340. 4 indexed citations
15.
Opdal, Siri H., Øyvind Melien, Helge Rootwelt, et al.. (2006). The G protein ?3 subunit 825C allele is associated with sudden infant death due to infection. Acta Paediatrica. 95(9). 1129–1132. 10 indexed citations
16.
Melien, Øyvind, et al.. (2005). Venlafaxine and asthma. Nordic Journal of Psychiatry. 59(6). 538–540. 6 indexed citations
17.
Melien, Øyvind, Per Wiik Johansen, Tone Westergren, & Hans Erik Rugstad. (2003). Vitamin K i matvarer og effekt av warfarin. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
18.
Jensen, Jørgen, et al.. (2003). Evidence that Nitroprusside Stimulates Glucose Uptake in Isolated Rat Cardiomyocytes via Mitogen-activated Protein Kinase. Archives of Physiology and Biochemistry. 111(3). 239–245. 9 indexed citations
19.
Melien, Øyvind, Per Wiik Johansen, Tone Westergren, & Hans Erik Rugstad. (2003). [Vitamin K in food and the effect of warfarin].. PubMed. 123(13-14). 1862–3. 1 indexed citations
20.
Refsnes, Magne, Dagny Sandnes, Øyvind Melien, et al.. (1983). Mechanisms for the emergence of catecholamine‐sensitive adenylate cyclase and β‐adrenergic receptors in cultured hepatocytes. FEBS Letters. 164(2). 291–298. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sudarshan Hebbar Breakdown of academic impact, for papers by Katalin Tóth Breakdown of academic impact, for papers by Stefania Giuliano Breakdown of academic impact, for papers by D. M. Burley Breakdown of academic impact, for papers by Inga Peter Breakdown of academic impact, for papers by Jin Peng Breakdown of academic impact, for papers by Jung‐Nien Lai Breakdown of academic impact, for papers by Karine Sargsyan Breakdown of academic impact, for papers by Monica Fujii Breakdown of academic impact, for papers by Yasuhiro Endo
Rankless by CCL
2026